Dosisjusteringer bør baseres på klinisk og radiologisk udredning såvel som ændringer i serum alkalisk fosfatase og udskillelse af hydroxyprolin i urinen.
Adjustments in dose should be guided by clinical and radiological evidence, as well as changes in serum alkaline phosphatase and urinary hydroxyproline excretion.